Emcure Pharma To Launch Molnupiravir For Emergency Use In A Week�s Time In India

[email protected]11 Jan, 2022News

Emcure Pharmaceuticals Limited (EPL) has received an Emergency Use Authorisation (EUA) approval from the Drug Controller General of India (DGCI) for the launch of Molnupiravir, an investigational oral antiviral drug, for the treatment of mild COVID-19. EPL plans to launch molnupiravir under the brand name Lizuvira in the Indian market.